Long-term risk of adverse outcomes according to atrial fibrillation type

Steffen Blum(University Hospital of Basel), Drahomir Aujesky(General Department of Preventive Medicine), Philipp Reddiess(University Hospital of Basel), Philipp Krisai(University Hospital of Basel), Peter Ammann(University of St.Gallen), Dipen Shah(Hôpital Cardiologique du Haut-Lévêque), Andreas U. Monsch(Felix Platter-Hospital), Rahel Müller(University Hospital of Basel), Marcello Di Valentino(Ospedale San Giovanni Bellinzona), Jürg H. Beer(University of Zurich), Maurin Lampart(University Hospital of Basel), Chloé Auberson(University Hospital of Basel), Ceylan Eken(University Hospital of Basel), Elisa Hennings(University Hospital of Basel), Nicolas Rodondi(General Department of Preventive Medicine), Anne Springer, Marc Girod(University Hospital of Basel), Thomas D. Szucs(University of Basel), Vasco Iten(University Hospital of Basel), Stefan Osswald(University Hospital of Basel), Elena Herber(University Hospital of Basel), Mirko Lischer(University Hospital of Basel), Pascal Meyre(University of Basel), Michael Kühne(University Hospital of Basel), Rebecca E. Paladini(University Hospital of Basel), David Conen(Yamaha (Japan)), Christian Sticherling(University Hospital of Basel), Leo H. Bonati(Reha Rheinfelden), Paul Erné(University of Zurich), Simone Evers-Doerpfeld(University Hospital of Basel), Elisavet Moutzouri(University of Bern), Christine Meyer‐Zürn, Stefanie Aeschbacher(University Hospital of Basel), Christian Müller(University Hospital of Basel), Michael Coslovsky(University Hospital of Basel), Gian Völlmin(University Hospital of Basel), Selinda Ceylan(University Hospital of Basel)
Scientific Reports
February 9, 2022
Cited by 20


Related Papers